Internal Medicine, Transplant Hepatology · San Francisco, CA
NPI
1780604645
Since 2006
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1100 Van Ness Ave
San Francisco, CA, 94109
Phone (415) 600-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
226 services
Medicare patients, 2024
105
Average age 74
Drug cost, 2024
$925K
761 prescriptions
Company payments, 2025
$19.9
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stewart Cooper was code 99215 (office e&m - established), 144 times for 82 patients. In total Stewart Cooper billed 226 services in 6 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 144 | 82 | $116.02 | $17K |
| 99215 Office E&M - Established | Office | 30 | 26 | $141.33 | $4,240 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 28 | 14 | $28.01 | $784 |
By year: 2022 $21K for 199 services; 2023 $22K for 201 services; 2024 $24K for 226 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stewart Cooper prescribed most often to Medicare patients was Vemlidy (Tenofovir Alafenamide), with 297 prescriptions and refills. In total Stewart Cooper wrote 761 Medicare prescriptions that cost $925K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vemlidy Tenofovir Alafenamide | 297 | 331 | 27 | $477K |
| Entecavir Generic | 102 | 246 | 19 | $59K |
| Tacrolimus Generic | 61 | 105 | Under 11 | $5,019 |
| Xifaxan Rifaximin | 39 | 45 | Under 11 | $151K |
| Pantoprazole Sodium Generic | 25 | 59 | Under 11 | $609 |
| Cyclosporine Modified Cyclosporine, Modified | 23 | 27 | Under 11 | $3,129 |
| Prednisone Generic | 23 | 53 | Under 11 | $250 |
| Ursodiol Generic | 22 | 46 | Under 11 | $4,184 |
| Azathioprine Generic | 20 | 37 | Under 11 | $439 |
| Ciprofloxacin Hcl Generic | 16 | 23 | Under 11 | $271 |
| Eplerenone Generic | 15 | 27 | Under 11 | $818 |
| Furosemide Generic | 15 | 29 | Under 11 | $80.21 |
| Mycophenolic Acid Mycophenolate Sodium | 14 | 37 | Under 11 | $4,954 |
| Sodium Phenylbutyrate Generic | 12 | 12 | Under 11 | $119K |
| Tenofovir Disoproxil Fumarate Generic | 11 | 31 | Under 11 | $9,531 |
Brand drugs: 355 claims; generic drugs: 406 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stewart Cooper $19.9 ($19.9 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $19.9.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $19.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.